Beta Bionics, Inc. IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...

Beta Bionics offers the iLet Bionic Pancreas, an FDA-cleared insulin delivery device with advanced algorithms. How can I obtain the IPO prospectus for Beta Bionics? The final prospectus for Beta ...

From the first “Touchdown!” shout to the most epic moments of every game, NFL mascots have certainly stolen the show. With just one look, they’ve reminded us that, in the end, football is only part of ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Beta Bionics began trading on Thursday after filing to go public in early January. The diabetes technology ...

The Harmony behind-the-ear (BTE) sound processor uses sophisticated technology to help adult or child - hear best at work, at school, or at play. When one hear the world’s full spectrum of sound ...

IRVINE, Calif. – Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share. The gross proceeds to ...

See the full release here. IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced ...

Beta Bionics celebrates its formal listing on the Nasdaq market. [Image from the company’s LinkedIn page] Beta Bionics (Nasdaq:BBNX) has gone public after pricing a significantly upsized initial ...

Beta Bionics Inc., an Irvine-based medical device company, today began publicly trading on the Nasdaq Capital Market under the ticker BBNX. The company raised an upsized offering of $204 million by ...

It was there that a biopsy uncovered the truth: Armando had Stage 4 metastatic urothelial carcinoma (mUC), also known as advanced bladder cancer. Bladder cancer is a serious, challenging disease ...

IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized ...

Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering. In a recent SEC filing, the company said it was now looking to offer 10M ...